# Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index
Canonical URL: https://biopharmsignal.com/news/LQDA/liquidia-corporation-announces-inclusion-in-the-sandp-smallcap-600r-index
Ticker: LQDA
Company: Liquidia Corporation
Source: Liquidia Corporation
Published: 2026-06-25 13:46 EST
Original Source URL: https://www.liquidia.com
## Summary

MORRISVILLE, N.C., June 08, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, announced today that it will be added to the S&P SmallCap

## Article Body
MORRISVILLE, N.C., June 08, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, announced today that it will be added to the S&P SmallCap
## Recent Company News
- 2026-06-25 13:46 EST — [Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions](https://biopharmsignal.com/news/LQDA/liquidia-announces-poster-presentations-at-the-pha-2026-international-ph-conference-and-scientific-sessions) — Source: Liquidia Corporation
- 2026-06-25 13:46 EST — [Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index](https://biopharmsignal.com/news/LQDA/liquidia-corporation-announces-inclusion-in-the-sandp-smallcap-600r-index) — Source: Liquidia Corporation
- 2026-06-25 13:46 EST — [Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/LQDA/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference) — Source: Liquidia Corporation
- 2026-06-25 13:46 EST — [Liquidia Corporation Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/LQDA/liquidia-corporation-reports-first-quarter-2026-financial-results) — Source: Liquidia Corporation
- 2026-06-25 13:46 EST — [Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/LQDA/liquidia-corporation-reports-third-quarter-2025-financial-results-and-provides-corporate-update) — Source: Liquidia Corporation
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)